Tetralogic Pharmaceu (TLOG) 0.22 $TLOG 4 Trending Small

New Post Public Reply Private Reply Replies (0) Message Board

Sep 1, 2016 at 5:14 PM

Tetralogic Pharmaceu (TLOG) 0.22 $TLOG

4 Trending Small Cap Stocks That You Need To Watch Today
ACCESSWIRE - Tue Apr 26, 7:27AM CDT
NEW YORK, NY / ACCESSWIRE / April 26, 2016 / The OTC Expert is issuing a report on four stocks that are trading with heavier than usual volume. LPTN, TLOG, HTM and VSTM are on high volume watch. Continue reading to find out why these stocks are getting so much interest today. - If you want reports on the day's hottest stocks (NYSE/Nasdaq/OTC) subscribe to our newsletter at otc-expert.com.
VSTM: 1.34 (-0.01), HTM: 0.72 (unch), LPTN: 2.37 (+0.02), TLOG: 0.22 (unch)

Penny Stocks To Watch: Four Top Small Cap Stocks on Monday April 25
ACCESSWIRE - Mon Apr 25, 11:44AM CDT
MIAMI, FL / ACCESSWIRE / April 25, 2016 / Daily Stock Reporter is issuing a report on four stocks to watch. TLOG, LPTN, OREX, and BTUUQ have been added to our watch list today. Continue reading to find out why. - To get daily alerts on top stocks on the OTC, Nasdaq and NYSE subscribe to our newsletter at DailyStockReporter.com.
OREX: 3.92 (-0.01), LPTN: 2.37 (+0.02), TLOG: 0.22 (unch)

James E. Goldschmidt, Ph.D. Joins CASI Pharmaceuticals As Vice President Of Business Development
PR Newswire - Mon Apr 18, 6:00AM CDT
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to innovative therapeutics addressing cancer and other unmet medical needs, welcomes James E. Goldschmidt, Ph.D. to lead its business development team. Dr. Goldschmidt is responsible for developing new partnerships and brings to the Company more than 25 years of biotechnology and pharmaceutical experience, including most recently at Macrophage Therapeutics, and prior thereto at ImmuneXcite, TetraLogic Pharmaceuticals, Johnson & Johnson, Wyeth Pharmaceuticals, and SmithKline Beecham. Dr. Goldschmidt is a graduate of Villanova University and holds a master's degree from Drexel University and a Ph.D. from Temple University School of Medicine.
JNJ: 119.08 (-0.26), CASI: 1.22 (+0.05), TLOG: 0.22 (unch)

Top Penny Stocks: Four Small Cap Stocks You Should Be Watching On April 15th
ACCESSWIRE - Fri Apr 15, 11:09AM CDT
MIAMI, FL / ACCESSWIRE / April 15, 2016 / Daily Stock Reporter is issuing a report on four stocks to watch. EBIO, EXXI, TLOG, and RMHB have been added to our watch list today. Continue reading to find out why. - To get daily alerts on top stocks on the OTC, Nasdaq and NYSE subscribe to our newsletter at DailyStockReporter.com.
EXXI: 0.13 (-0.01), EBIO: 4.89 (+0.01), TLOG: 0.22 (unch)

These Biotech Companies are Helping Turn Around the Sector for Major Gains in 2016
ACCESSWIRE - Wed Feb 03, 12:50PM CST
LAS VEGAS, NV / ACCESSWIRE / February 3, 2016 / The most notable of the pack is Propanc Health Group Corporation (PPCH), which is an exciting, young company within the sector. Propanc, whose focus is the development of new and proprietary treatments for cancer patients suffering from pancreatic, ovarian and colorectal cancers, recently announced the Company received a further $525,000 tranche from an institutional investor in order to progress their lead product, PRP, towards human trials. PPCH has already grabbed the attention of more than a few investors thanks to the Company's substantial growth in 2015 and expected growth in 2016.
RPTP: 7.24 (-0.21), TTNP: 5.68 (+0.06), MNKD: 0.73 (-0.07), TLOG: 0.22 (unch)

Insider Alert: Here's Why These Small Caps Could Be Ready To Bounceâ?¦
ACCESSWIRE - Wed Jan 13, 8:45AM CST
NEW YORK, NY / ACCESSWIRE / January 13, 2016 / UltimateStockAlerts.com is a NASDAQ & NYSE Only Stock Alerts Service focused on day trading, swing trading and long-term investing. Our newsletter subscribers have witnessed upside in excess of 600% with realized gains of 296% in 2015 from 32 alerts. Receive free trade alerts via email or text message (SMS) on your phone by texting message ULTIMATE to number 555-888. Today we are taking a look at four companies which we believe could provide investors with significant volatility in the near term.
TLOG: 0.22 (unch)

TetraLogic Pharmaceuticals Announces Data on Lead Clinical Programs
GlobeNewswire - Wed Jan 06, 3:11PM CST
Birinapant Shows No Activity in Randomized Phase 2 MDS Study
TLOG: 0.22 (unch)

Global Cutaneous T-Cell Lymphoma Therapeutics Pipeline Review, H2 2015 - 21 Companies & 24 Drug Profiles
M2 - Thu Dec 03, 7:30AM CST
Research and Markets (http://www.researchandmarkets.com/research/9fwsbh/cutaneous_tcell) has announced the addition of the "Cutaneous T-Cell Lymphoma - Pipeline Review, H2 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Cutaneous T-Cell Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cutaneous T-Cell Lymphoma and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - 4SC AG - Affimed Therapeutics AG - Chipscreen Biosciences Ltd - Cornerstone Pharmaceuticals, Inc. - Cyclacel Pharmaceuticals, Inc. - Eisai Co., Ltd. - Galderma S.A. - Innate Pharma SA - Johnson & Johnson - Karyopharm Therapeutics, Inc. - Kyowa Hakko Kirin Co., Ltd. - MedImmune, LLC - Neumedicines Inc. - Novartis AG - OncoSec Medical Inc. - Onyx Pharmaceuticals, Inc. - Sanofi - Seattle Genetics, Inc. - Soligenix, Inc. - Taiwan Liposome Company, Ltd. - TetraLogic Pharmaceuticals Drug Profiles - A-dmDT390-bisFv - AFM-13 - alemtuzumab - AMP-224 - Angeloxin - bexarotene - brentuximab vedotin - carfilzomib - CIGB-128 - CPI-613 - CS-055 - DNA IL-12 - everolimus - IPH-4102 - mogamulizumab - NMIL-121 - quisinostat hydrochloride - resminostat - sapacitabine - selinexor - SGX-301 - SHP-141 - trifarotene - vinorelbine tartrate For more information visit http://www.researchandmarkets.com/research/9f...eous_tcell
TLOG: 0.22 (unch), JNJ: 119.08 (-0.26), CYCC: 5.71 (+0.04), SGEN: 44.90 (+0.35), ONCS: 1.71 (+0.02), KPTI: 11.10 (+1.15), NVS: 78.27 (-0.50)

TetraLogic Pharmaceuticals Announces Clinical Data on Birinapant to be Presented at the 57th Annual American Society of Hematology Annual Meeting
GlobeNewswire - Mon Nov 09, 6:00AM CST
TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that two abstracts discussing clinical data on birinapant will be presented at the 57 Annual American Society of Hematology meeting to be held in Orlando from December 5-8, 2015, one of which is to be an oral presentation.
TLOG: 0.22 (unch)

TetraLogic Reports Third Quarter Financial Results and Provides Clinical Programs Update
GlobeNewswire - Wed Nov 04, 3:02PM CST
TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics in oncology and infectious diseases, today announced financial results for the third quarter ended September 30, 2015. These results are included in TetraLogic's Quarterly Report on Form 10-Q which has been filed with the Securities and Exchange Commission.
TLOG: 0.22 (unch)

TetraLogic Announces the Opening of an IND for SHAPE Gel in Alopecia Areata
GlobeNewswire - Mon Nov 02, 6:00AM CST
TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that it has an open U.S. Investigational New Drug application in support of a Phase 2 clinical trial of suberohydroxamic acid (4-methoxycarbonyl) phenyl ester (SHAPE) in approximately forty patients with alopecia areata.
TLOG: 0.22 (unch)

Pharmaceutical Sector Due Diligence Report - Searching for Opportunities Among the Bruised Small Cap Market
ACCESSWIRE - Wed Oct 07, 7:14AM CDT
NEW YORK, NY / ACCESSWIRE / October 7, 2015 / We profile four development stage companies with exciting prospects for future growth. In the report, we describe the companies, their products and provide recommendations on which have the better prospects to realize their growth potential.
CTRV: 1.16 (+0.01), TROV: 4.96 (+0.05), TLOG: 0.22 (unch), KERX: 4.13 (+0.03)

TetraLogic Reports Second Quarter Financial Results and Provides Clinical Programs Update
GlobeNewswire - Wed Aug 05, 3:01PM CDT
TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics in oncology and infectious diseases, today announced financial results for the second quarter ended June 30, 2015. These results are included in TetraLogic's Quarterly Report on Form 10-Q which has been filed with the Securities and Exchange Commission.
TLOG: 0.22 (unch)

TetraLogic to Present at the Jefferies 2015 Hepatitis B Summit
GlobeNewswire - Wed Jul 29, 6:32AM CDT
TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) today announced that the Company will present at the Jefferies 2015 Hepatitis B Summit on Thursday, August 6, 2015 at 1:45 p.m. Eastern Time at the Boston Harbor Hotel. J. Kevin Buchi, CEO, will provide an overview of the Company, the Hepatitis B program and its corporate activities.
TLOG: 0.22 (unch)

TetraLogic Provides Update on Hepatitis B Clinical Program
GlobeNewswire - Mon Jul 20, 3:02PM CDT
TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) a clinical-stage biopharmaceutical company focuses on discovering and developing novel small molecule therapeutics in oncology and infectious diseases, today provided an update on the status of its hepatitis B virus (HBV) clinical program.
TLOG: 0.22 (unch)

Updates on MDS Clinical Program - Free Research Report on TetraLogic Pharmaceuticals Corporation
PR Newswire - Wed Jul 15, 8:10AM CDT
ACI Association has initiated research coverage on TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG). Select highlights from the internally released reports are being made available to the general public (included below), with access to the entirety of the research available to new members.
TLOG: 0.22 (unch)

TetraLogic Announces Update on MDS Clinical Program
GlobeNewswire - Tue Jun 30, 3:01PM CDT
TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics in oncology and infectious diseases, today announced preliminary data from the ongoing Phase 2A study of birinapant in combination with azacitidine in first line higher risk myelodysplastic syndromes (MDS). The study is being conducted as a precursor to the ongoing randomized Phase 2B study.
TLOG: 0.22 (unch)

Tracking the Pulse of the Healthcare Sector: Complementary Research on Corbus, Vascular Biogenics, Alexza, TetraLogic and Cleveland BioLabs
PR Newswire - Mon May 18, 6:50AM CDT
Editor Note: For more information about this release, please scroll to bottom.
CRBP: 4.20 (+0.11), CBLI: 1.99 (+0.03), VBLT: 4.06 (-0.05), TLOG: 0.22 (unch)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Medicare Payment Proposal Faces Doctor Backlash in D.C.

Why Same-Day Medicare Care Matters Imagine you're gasping for breath, struggling to find relief, and then being told to wait weeks for care. It's not just an inconvenience; it's a health hazard. This isn't some arbitrary tale—it's the gritty reality for folks relying on same-day care. A group of docs and advocates recently stormed Capitol Hill sounding the alarm about a...

University of Phoenix Grads Shine in Job Readiness

University of Phoenix Graduates Proving Their Worth Dive straight into the world of University of Phoenix grads, and you're looking at some folks who seem to have the workplace game figured out. A fresh Harris Poll, done on behalf of the University itself, paints a rosy picture of these graduates from the eyes of those who actually supervise them. Turns out, managers are...

Crucial Insights for South GA Home Insurance Choices

Understanding the Insurance Jargon Here we go again, dealing with insurance gobbledygook that’s about as clear as mud to most of us. Homeowners in South Georgia are being urged to pay attention to the differences between replacement cost and actual cash value in their insurance policies. This ain't just legalese, folks—it's your protection when disaster strikes in our...

Superga and Pasqua's Unlikely Fashion-Vineyard Fusion

Superga and Pasqua: A Fusion of Fashion and Vineyards Here's one for the books: Superga, the storied Italian footwear maestro, teaming up with Pasqua Wines, straight out of Verona’s vineyard heartland. On the surface, it seems a rather odd coupling. One's got rubber soles; the other’s got corks. But they’ve pulled off a daring bedroom switch, creating a...

EPR Fireworks, Schedule2.IT Enhance EMS Integration

Joining Forces for Effective EMS Management In a move that could shake up emergency medical services, EPR Fireworks has teamed up with Schedule2.IT to amp up integration. This Florida-based partnership is all about breaking down those bureaucratic firewalls between patient care and controlled substances tracking. They’re pushing for a seamless workflow, where crucial...

FSS Unveils AI Tool to Simplify Bankruptcy Cases

AI Revolution in Bankruptcy Management Alright, folks, there's a fresh breeze blowing in the bankruptcy management world, and it bears the acronym FSS. Financial Software Solutions is rolling out its innovative FSS Intelligence Engine. This little powerhouse aims to turn what used to be a gut-wrenching slog through mountains of paperwork into a slick, automated process....

JennAir and Cosentino Introduce Seamless Kitchen Aesthetics

It's not every day that the kitchen landscape gets a bold makeover, but JennAir and Cosentino seem to think it's time. Introducing their latest splash, the JennAir x Dekton panel collection is here to redefine what luxury kitchens can look like—an embodiment of seamless beauty that’s more sculpture than cooking space. Elevating Kitchen Design So, what's the buzz about...

Roof Replacement Timelines: Key Insights for PA Homeowners

There's no denying it; having a roof over your head is one thing, but knowing when to replace it is a whole other ballgame. In Pennsylvania, where the weather loves to throw curveballs, making the right call on roof replacement can save a heap of trouble down the road. Thanks to Miguel Cornejo and his insights in HelloNation’s latest rundown, we get a clearer picture of...

Vortex Expands UK Reach with Torrent Acquisition Boost

Vortex's Ambitious UK Expansion A seasoned investor keen on infrastructure plays would find Vortex Companies’ latest move significant—not just another acquisition, but a realigned strategy for dominance as Britain braces for an infrastructure overhaul. With Torrent Drainage Services in their pocket, the Vortex Group plans to amp up its trenchless rehabilitation...

Reel Wheels: Hollywood's Iconic Car Collection Unveiled

Rolling Out the Legends: A Peek Inside Reel Wheels Picture something that screams Hollywood. Now, give it wheels, maybe some wings too. That's what Reel Wheels Entertainment has laid out—a mind-boggling assortment of film and TV vehicles. Released on September 30, 2026, this collection is a treasure trove of Hollywood's on-screen memorabilia, and they're not just...